CIONIC Closes Additional $12 Million Series A Financing

San Francisco, CA-based CIONIC has closed a $12 million Series A extension led by L Catterton, with participation from new investor THVC and all existing investors, bringing the total Series A funding to $25 million.

The funds will be used to expand user and physician adoption of the Cionic Neural Sleeve for the millions of people with mobility impairments caused by multiple sclerosis, stroke, cerebral palsy and other neurological conditions. CIONIC will also use the funds to accelerate the company’s product pipeline into new indications that address the full spectrum of human mobility. This roadmap will be supported by continued investment in CIONIC’s wearable neuromodulation platform.

CIONIC has doubled its headcount in the past six months and established a state-of-the-art manufacturing facility in Northern California. The company is now licensed to ship the Cionic Neural Sleeve to 45 states in the US, with over 400 prescribing institutions. Since the start of shipments in early 2023, CIONIC customers have already clocked over 200,000 hours of use.